635
Views
4
CrossRef citations to date
0
Altmetric
Review

Potential Nutraceutical Use of Tribulus terrestris L. in Human Health

, , , , , ORCID Icon & ORCID Icon show all
 

ABSTRACT

Tribulus terrestris (T. terrestris) is an herb that has been used in various traditional medicine practices since ancient times. More recently, the pronounced health benefits of this herb have been evaluated within a wide scope, without properly acknowledging its nutraceutical value. Therefore, this article intends to provide an integrated overview on the nutraceutical potential of T. terrestris in the area of human health promotion. This review discusses the potential employability of T. terrestris and its derived products as nutraceuticals in prevention, treatment, and management of prevalent human diseases and associated conditions. The outcomes of several in vitro and in vivo studies elaborate on the ability of T. terrestris supplements and different fractions to act as antioxidant, anti-inflammatory, anticancer, antidiabetic, testosterone boosting, and cardio, renal and liver protective agents. Many studies reveal that T. terrestris would act as an excellent nutraceutical that prevents harmful impacts to the human body. Its bioactivities are driven by various factors, and it has been suggested to be used to replace certain pharmaceuticals and synthetic drugs. In-depth clinical studies on the herbal pharmacodynamics are needed and would broaden the scope of nutraceutical applications of T. terrestris.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Author contribution

J.Lu. conceived the idea, R.G. & H.N. performed the review and wrote the initial draft, A.L. drew and prepared the graphs, J.Li, T.Y., B.Z. and J.Lu edited the draft.

Additional information

Funding

This research was funded by New Zealand National Science Challenge High Value Nutrition (grant number HVN 3719491 1905), Beyond Capital MedTech Management Limited (grant AUT-12732 & 12733), Ministry of Education New Zealand, NZ-China Tripartite Research Fund (AUT-13772), and the Royal Society of New Zealand Catalyst Seeding Fund (21-AUT-005-CSG); Beyond Capital MedTech Management Ltd [AUT 12732 and 12733]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.